Nanoparticle technology: Amplifying the effective sensitivity of biomarker detection to create a urine test for hGH

Drug Testing and Analysis

Volumn 1, Issue 9-10, 2009, Pages 447-454

  Fredolini, Claudia ^a,b,e   Tamburro, Davide ^c,e   Gambara, Guido ^d,e   Lepene, Benjamin S ^f   Espina, Virginia ^e   Petricoin III, Emanuel F ^e   Liotta, Lance A ^e   Luchini, Alessandra ^e  

^a S GIOVANNI BOSCO HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^e GEORGE MASON UNIVERSITY   (United States)

^f CERES NANOSCIENCES INC   (United States)

Author keywords

Biomarkers; Cibacron blue F3GA; hGH; Immunoassay; Nanoparticles; Urine

Indexed keywords

ACRYLIC MONOMERS; AMIDES; BIOMARKERS; BODY FLUIDS;

ANALYTES; CIBACRON BLUE F3GA; FUNCTIONALIZED; HGH; IMMUNOASSAY; ISOFORMS; MEASUREMENTS OF; NANOPARTICLE TECHNOLOGIES; URINE; URINE TEST;

NANOPARTICLES;

BETA 2 MICROGLOBULIN; HUMAN GROWTH HORMONE; NANOPARTICLE;

ABSORPTION; ACCURACY; AFFINITY CHROMATOGRAPHY; BINDING AFFINITY; BINDING SITE; CHEMICAL STRUCTURE; CHEMOLUMINESCENCE; CONFERENCE PAPER; DEGRADATION; DOPING; DRUG SCREENING; GLOMERULUS FILTRATION RATE; HUMAN; HYDROGEL; IMMUNOASSAY; KIDNEY FUNCTION; METABOLIC CLEARANCE RATE; MOLECULAR WEIGHT; NANOTECHNOLOGY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; URINALYSIS;

EID: 77953449326     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.96     Document Type: Conference Paper

References (48)

1. M. Bidlingmaier, C. J. Strasburger, Pituitary 2007, 10, 115.
2. V. Popii, G. Baumann, Clin. Chim. Acta 2004, 350, 1.
3. A. Giustina, J. D. Veldhuis, Endocr. Rev. 1998, 19, 717.
4. M. Saugy, N. Robinson, C. Saudan, N. Baume, L. Avois, P. Mangin, Br. J. Sports Med. 2006, 40(Suppl 1), i35.
5. N. E. Felsing, J. A. Brasel, D. M. Cooper, J. Clin. Endocrinol. Metab. 1992, 75, 157.
6. C. Lassarre, F. Girard, J. Durand, J. Raynaud, J. Appl. Physiol. 1974, 37, 826.
7. M. L. Parker, R. D. Utiger, W. H. Daughaday, J. Clin. Invest. 1962, 41, 262.
8. E. F. De Palo, R. Gatti, G. Antonelli, P. Spinella, Clin. Chim. Acta 2006, 364, 77.
9. S. Momomura, Y. Hashimoto, Y. Shimazaki, M. Irie, Endocr. J. 2000, 47, 97.
10. M. Bidlingmaier, J. Suhr, A. Ernst, Z. Wu, A. Keller, C. J. Strasburger, A. Bergmann, Clin. Chem. 2009, 55, 445.
11. M. Saugy, C. Cardis, L. Rivier, G. Brisson, C. Ayotte, P. E. Hemmersbach Haug, J. Segura, Recent Advances in Doping Analysis 1995, 2, 223.
12. G. Baumann, E. C. Abramson, J. Clin. Endocrinol. Metab. 1983, 56, 305.
13. A. M. Skinner, P. E. Clayton, D. A. Price, G. M. Addison, C. Y. Mui, J. Endocrinol. 1993, 138, 337.
14. G. Turner, R. C. Brown, I. Weeks, G. E. Butler, F. N. Creagh, J. S. Woodhead, Ann. Clin. Biochem. 1993, 30(2), 180.
15. K. Main, M. Philips, M. Jorgensen, N. E. Skakkebaek, Horm. Res. 1991, 36, 174.
16. N. Hattori, A. Shimatsu, Y. Kato, H. Imura, Kidney Int. 1990, 37, 951.
17. M. Bidlingmaier, Eur J Endocrinol 2008, 159(Suppl 1), S41.
18. P. Hourd, R. Edwards, J. Endocrinol. 1989, 121, 167.
19. M. Saugy, C. Cardis, C. Schweizer, J. L. Veuthey, L. Rivier, J. Chromatogr. B Biomed. Appl. 1996, 687, 201.
20. Z. Wu, M. Bidlingmaier, R. Dall, C. J. Strasburger, Lancet 1999, 353, 895.
21. D. E. Flanagan, M. C. Taylor, V. Parfitt, R. Mardell, P. J. Wood, B. A. Leatherdale, Clin. Endocrinol. (Oxf.) 1997, 46, 425.
22. A. S. Bates, A. J. Evans, P. Jones, R. N. Clayton, Clin. Endocrinol. (Oxf.) 1995, 42, 425.
23. A. S. Bates, A. J. Evans, P. Jones, and R. N. Clayton, Clin. Endocrinol. (Oxf.) 1995, 42, 417.
24. J. Girard, Nucl. Med. Biol. 1994, 21, 381.
25. J. Girard, T. Fischer-Wasels, Horm. Res. 1990, 33(Suppl 4), 12.
26. K. M. Main, J. Lindholm, M. Vandeweghe, N. E. Skakkebaek, Acta Endocrinol. (Copenh.) 1993, 129, 409.
27. P. M. Pirazzoli, M. Mandini, S. Zucchini, S. Gualandi, L. Vignutelli, M. Capelli, E. Cacciari, Arch. Dis. Child. 1996, 75, 228.
28. D. Porquet, O. Rigal, D. E. Brion, F. Valade, J. Leger, P. Czernichow, Clin. Chem. 1992, 38, 1717.
29. A. Sartorio, E. Palmieri, V. Vangeli, G. Conte, M. Narici, G. Faglia, J. Endocrinol. Invest. 2001, 24, 515.
30. L. M. Winer, M. A. Shaw, G. Baumann, J. Endocrinol. Invest. 1989, 12, 461.
31. K. M. Main, C. Jansson, N. Skakkebak, K. Albertsson-Wikland, Horm. Res. 1997, 48, 16.
32. J. Leger, C. Reverchon, D. Porquet, M. Noel, P. Czernichow, Horm. Res. 1995, 44, 57.
33. K. Murao, J. Takahara, M. Sato, M. Tamaki, M. Niimi, T. Ishida, Endocr. J. 1994, 41, 517.
34. J. Aman, I. Jones, Scand. J. Clin. Lab. Invest. 1994, 54, 227.
35. S. Braschi, A. Faivre, B. Charbonnel, Pathol. Biol. (Paris) 1994, 42, 621.
36. J. Geller, A. Loh, J. Clin. Endocrinol. Metab. 1963, 23, 1107.
37. P. Hourd, R. Edwards, Clin. Endocrinol. (Oxf.) 1994, 40, 155.
38. M. H. Lin, D. Y. Lin, J. Formos. Med. Assoc. 1993, 92, 807.
39. M. G. McConway, K. A. Smith, G. H. Beastall, Ann. Clin. Biochem. 1999, 36(5), 649.
40. A. E. Nelson, K. K. Ho, Asian J. Androl. 2008, 10, 416.
41. C. Fredolini, F. Meani, K. A. Reeder, S. Rucker, A. Patanarut, P. J. Botterell, B. Bishop, C. Longo, V. Espina, E. F. I. Petricoin, L. A. Liotta, A. Luchini, Nano Research 2008, 1, 502.
42. C. Longo, A. Patanarut, T. George, B. Bishop, W. Zhou, M. M. Ross, V. Espina, G. Pellacani, E. F. I. Petricoin, L. A. Liotta, A. Luchini, PLoS One 2009, 4, e4763.
43. A. Luchini, D. H. Geho, B. Bishop, D. Tran, C. Xia, R. L. Dufour, C. D. Jones, V. Espina, A. Patanarut, W. Zhou, M. M. Ross, A. Tessitore, E. F. Petricoin, L. A. Liotta, Nano. Lett. 2008, 8, 350.
44. A. Luchini, C. Longo, V. Espina, E. I. Petricoin, L. Liotta, J. Mater. Chem. 2009, 19, 5071 DOI: 10.1039/b822264a.
45. A. Denizli, E. Piskin, J. Biochem. Biophys. Methods 2001, 49, 391.
46. C. R. Lowe, J. C. Pearson, Methods Enzymol. 1984, 104, 97.
47. J. Sereikaite, V. A. Bumelis, Biomed Chromatogr 2006, 20, 195.
48. B. Salih, R. Zenobi, Anal. Chem. 1998, 70, 1536.